[Press Release] Global Vascular Raises 1 Billion Yen in Series B Funding
- 由妃乃 尾崎
- Jun 30
- 1 min read
Updated: Aug 1
Global Vascular Co., Ltd. (Headquarters: Tokyo, Japan), a company developing a next-generation medical device specializing in the treatment of Peripheral Artery Disease (PAD) in the legs, has successfully raised a total of 1 billion yen in Series B funding. With this round, the company has raised a cumulative total of 2.77 billion yen since its founding.
Investors in this round include Diamond Medino Capital Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., Sumitomo Mitsui Trust Bank, Limited, MITSUI SUMITOMO INSURANCE Venture Capital Co., Ltd., Medikit Co., Ltd., Fast Track Initiative, Inc., Tokyo University of Science Innovation Capital Co., Ltd., and Tokyo University of Science Investment Management Co., Ltd., among others.
[About Global Vascular]
Global Vascular Co., Ltd. is a deep tech startup that originated from a university-based medical engineering collaboration group. The company's mission is "Towards a Future Where Walking is Guaranteed." Led by representative directors Kenta Bito, Ph.D., and Shunto Maegawa, Ph.D., Global Vascular is dedicated to developing the world's first cutting-edge endovascular treatment (EVT) with a proprietary drug-eluting stent delivery system incorporating a uniquely biocompatible material.
[Press Release on PR TIMES | June 30, 2025]
For inquiries concerning this matter, please contact us via the form provided below: